NCT06771063 - A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

July 10, 2025

Study Completion Date

July 31, 2025

Conditions

Vaginitis

Interventions

DRUG

WXSH0102/placebo

Administer WXSH0102 tablets/placebo orally.

DRUG

fluconazole capsules/placebo

Administer fluconazole capsules/placebo orally

Trial Locations (2)

NOT_YET_RECRUITING

251 Yaojiayuan Road, Chaoyang District, Beijing, Beijing

RECRUITING

Beijing Obstetrics and Gynecology Hospital, Beijing